Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Physical Review Letters
|
May 14, 2021
Testing Quantum Electrodynamics with Exotic Atoms
Nancy Paul, Guojie Bian, Toshiyuki Azuma, et al.
Journal of Medical Economics
|
July 19, 2023
Early access for innovative oncology medicines: a different story in each nation
Tara Cowling, Ransi Nayakarathna, Allison L Wills, et al.
Journal of Palliative Care
|
February 6, 2010
Satisfaction with end-of-life care: a longitudinal study of patients and their family caregivers in the last months of life
Daren K Heyland, Christopher Frank, Joan Tranmer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 12, 2002
Factors affecting workload of cancer clinical trials: results of a multicenter study of the National Cancer Institute of Canada Clinical Trials Group
Kathyrn Roche, Nancy Paul, Bobbi Smuck, et al.
Journal of Comparative Effectiveness Research
|
April 24, 2025
Time-limited reimbursement and Temporary Access Process for early access to oncology treatments in Canada: a perspective based on the epcoritamab experience
Chakrapani Balijepalli, Lakshmi Gullapalli, Swati Prasad, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 30, 2005
Randomized trial comparing cyclophosphamide, epirubicin, and fluorouracil with cyclophosphamide, methotrexate, and fluorouracil in premenopausal women with node-positive breast cancer: update of National Cancer Institute of Canada Clinical Trials Group Trial MA5
Mark N Levine, Kathleen I Pritchard, Vivien H C Bramwell, et al.
Cancers
|
September 28, 2024
The Economic Impact of Treatment Sequencing in Chronic Lymphocytic Leukemia in Canada Using Venetoclax plus Obinutuzumab
Kimberly Guinan, Karine Mathurin, Jean Lachaine, et al.
Journal of Comparative Effectiveness Research
|
April 20, 2026
Health care resource use in the management of patients with relapsed/refractory diffuse large B-cell lymphoma - Canadian perspective
Kimberly Guinan, Mathieu Pelletier, Monika Ham, et al.
Pharmacoeconomics - Open
|
November 7, 2025
Venetoclax in Combination with Obinutuzumab in Previously Untreated Fit Patients with Chronic Lymphocytic Leukemia: A Canadian Cost-Utility Analysis
Gijs van de Wetering, Carolyn Owen, Versha Banerji, et al.
Cancer
|
September 24, 2004
Gemcitabine, dexamethasone, and cisplatin in patients with recurrent or refractory aggressive histology B-cell non-Hodgkin lymphoma: a Phase II study by the National Cancer Institute of Canada Clinical Trials Group (NCIC-CTG)
Michael Crump, Tara Baetz, Stephen Couban, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Physical Review Letters
|
May 14, 2021
Testing Quantum Electrodynamics with Exotic Atoms
Nancy Paul, Guojie Bian, Toshiyuki Azuma, et al.
Journal of Medical Economics
|
July 19, 2023
Early access for innovative oncology medicines: a different story in each nation
Tara Cowling, Ransi Nayakarathna, Allison L Wills, et al.
Journal of Palliative Care
|
February 6, 2010
Satisfaction with end-of-life care: a longitudinal study of patients and their family caregivers in the last months of life
Daren K Heyland, Christopher Frank, Joan Tranmer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 12, 2002
Factors affecting workload of cancer clinical trials: results of a multicenter study of the National Cancer Institute of Canada Clinical Trials Group
Kathyrn Roche, Nancy Paul, Bobbi Smuck, et al.
Journal of Comparative Effectiveness Research
|
April 24, 2025
Time-limited reimbursement and Temporary Access Process for early access to oncology treatments in Canada: a perspective based on the epcoritamab experience
Chakrapani Balijepalli, Lakshmi Gullapalli, Swati Prasad, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 30, 2005
Randomized trial comparing cyclophosphamide, epirubicin, and fluorouracil with cyclophosphamide, methotrexate, and fluorouracil in premenopausal women with node-positive breast cancer: update of National Cancer Institute of Canada Clinical Trials Group Trial MA5
Mark N Levine, Kathleen I Pritchard, Vivien H C Bramwell, et al.
Cancers
|
September 28, 2024
The Economic Impact of Treatment Sequencing in Chronic Lymphocytic Leukemia in Canada Using Venetoclax plus Obinutuzumab
Kimberly Guinan, Karine Mathurin, Jean Lachaine, et al.
Journal of Comparative Effectiveness Research
|
April 20, 2026
Health care resource use in the management of patients with relapsed/refractory diffuse large B-cell lymphoma - Canadian perspective
Kimberly Guinan, Mathieu Pelletier, Monika Ham, et al.
Pharmacoeconomics - Open
|
November 7, 2025
Venetoclax in Combination with Obinutuzumab in Previously Untreated Fit Patients with Chronic Lymphocytic Leukemia: A Canadian Cost-Utility Analysis
Gijs van de Wetering, Carolyn Owen, Versha Banerji, et al.
Cancer
|
September 24, 2004
Gemcitabine, dexamethasone, and cisplatin in patients with recurrent or refractory aggressive histology B-cell non-Hodgkin lymphoma: a Phase II study by the National Cancer Institute of Canada Clinical Trials Group (NCIC-CTG)
Michael Crump, Tara Baetz, Stephen Couban, et al.
Page
of 2